Using QST in pharma-sponsored analgesic clinical trials: insights from recent trials
Monday, 3 December 2018
Quantitative Sensory testing (QST) is a well-established, gold-standard technique to quantitatively assess the peripheral small fibers functionality and central pain processing. Recent advances, including the development of new devices, methods, training solutions and normative data all support the growing embrace of QST into the complex arena of clinical drug development programs. Among other uses are phenotyping to predict treatment response, and assessment efficacy or safety endpoints. Insights from recent programs in which QST was utilized, and the potential benefit to the sponsors will be discussed.